Lunaphore launches Comet antibody instrument in U.K.

By The Science Advisory Board staff writers

May 9, 2022 -- Lunaphore installed its Comet Primary Antibodies (PA) instrument at Propath U.K., the first contract research organization (CRO) in Europe to offer the service.

Comet PA is an automated sequential immunofluorescence (seqIF) instrument that performs hyperplex staining and imaging. It allows multiplex analysis of up to 40 different spatial markers per tissue slide without human intervention, according to Lunaphore.

The instrument can aid understanding in the areas of immuno-oncology, neuroscience, and infectious diseases, the firm added.

Copyright © 2022

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter